Oberweis Asset Management Inc Coherus Bio Sciences, Inc. Transaction History

Oberweis Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$17.41 - $19.89 $388,243 - $443,547	-22,300 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$14.43 - $19.16 $199,134 - $264,408	-13,800 Reduced 38.23%	22,300 $398,000
Q1 2020 May 15, 2020	SELL	$11.67 - $22.53 $17,505 - $33,795	-1,500 Reduced 3.99%	36,100 $586,000
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $614,007 - $803,512	37,600 New	37,600 $677,000

132

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oberweis Asset Management Inc with notifications on news.